{"entity":{"type":"insider","cik":"0001423838","url":"/insider/0001423838","json_url":"/insider/0001423838.json","name":"Grigoriadis Dimitri E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":88,"n_filings":63,"first":"2008-02-06","last":"2021-10-12","span_basis":"filed_date"},"name_variants":[{"name":"Grigoriadis Dimitri E.","source":"filing","n_filings":63,"first_seen":"2008-02-06","last_seen":"2021-10-12"}],"transactions":[{"id":4741435,"accession":"0001209191-21-060281","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060281","line_url":"/filing/0001209191-21-060281","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":104.8137875,"price_display":"104.81","price_state":"stated","total_value":838510.3,"total_display":"838,510.30","total_whole":"838,510","shares_owned_after":82273.0,"shares_owned_after_display":"82,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-07","filed_date":"2021-10-12","scope":"insider","n_lines":2},{"id":4362417,"accession":"0001209191-21-009119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009119","line_url":"/filing/0001209191-21-009119","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2708.0,"shares_display":"2,708","price_per_share":116.69100284342689,"price_display":"116.69","price_state":"stated","total_value":315999.2357,"total_display":"315,999.24","total_whole":"315,999","shares_owned_after":85273.0,"shares_owned_after_display":"85,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":4362409,"accession":"0001209191-21-009119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009119","line_url":"/filing/0001209191-21-009119#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":605.0,"shares_display":"605","price_per_share":113.7563,"price_display":"113.76","price_state":"stated","total_value":68822.5615,"total_display":"68,822.56","total_whole":"68,823","shares_owned_after":82169.0,"shares_owned_after_display":"82,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":2120097,"accession":"0001209191-20-058547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058547","line_url":"/filing/0001209191-20-058547#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":90.7327,"price_display":"90.73","price_state":"stated","total_value":204783.7039,"total_display":"204,783.70","total_whole":"204,784","shares_owned_after":81624.0,"shares_owned_after_display":"81,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":2381447,"accession":"0001209191-20-045758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045758","line_url":"/filing/0001209191-20-045758#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":118.8302,"price_display":"118.83","price_state":"stated","total_value":268199.7614,"total_display":"268,199.76","total_whole":"268,200","shares_owned_after":79593.0,"shares_owned_after_display":"79,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2682575,"accession":"0001209191-20-031028","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-031028","line_url":"/filing/0001209191-20-031028","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42749.0,"shares_display":"42,749","price_per_share":126.55110995578843,"price_display":"126.55","price_state":"stated","total_value":5409933.3995,"total_display":"5,409,933.40","total_whole":"5,409,933","shares_owned_after":71992.0,"shares_owned_after_display":"71,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-20","scope":"insider","n_lines":2},{"id":2682560,"accession":"0001209191-20-031028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031028","line_url":"/filing/0001209191-20-031028#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":119.98,"price_display":"119.98","price_state":"stated","total_value":1199800.0,"total_display":"1,199,800.00","total_whole":"1,199,800","shares_owned_after":104741.0,"shares_owned_after_display":"104,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":3256718,"accession":"0001209191-20-028392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028392","line_url":"/filing/0001209191-20-028392#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8682.0,"shares_display":"8,682","price_per_share":105.4428,"price_display":"105.44","price_state":"stated","total_value":915454.3896,"total_display":"915,454.39","total_whole":"915,454","shares_owned_after":104741.0,"shares_owned_after_display":"104,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider"},{"id":2435702,"accession":"0001209191-20-026069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026069","line_url":"/filing/0001209191-20-026069#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1934.0,"shares_display":"1,934","price_per_share":99.4096,"price_display":"99.41","price_state":"stated","total_value":192258.1664,"total_display":"192,258.17","total_whole":"192,258","shares_owned_after":113423.0,"shares_owned_after_display":"113,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-28","scope":"insider"},{"id":2074692,"accession":"0001209191-20-008498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008498","line_url":"/filing/0001209191-20-008498#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1218.0,"shares_display":"1,218","price_per_share":103.3108,"price_display":"103.31","price_state":"stated","total_value":125832.5544,"total_display":"125,832.55","total_whole":"125,833","shares_owned_after":111682.0,"shares_owned_after_display":"111,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-11","scope":"insider"},{"id":3037836,"accession":"0001209191-20-007691","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-007691","line_url":"/filing/0001209191-20-007691#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":803.0,"shares_display":"803","price_per_share":101.4398,"price_display":"101.44","price_state":"stated","total_value":81456.1594,"total_display":"81,456.16","total_whole":"81,456","shares_owned_after":110587.0,"shares_owned_after_display":"110,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-07","scope":"insider"},{"id":3037832,"accession":"0001209191-20-007691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-007691","line_url":"/filing/0001209191-20-007691","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1618.0,"shares_display":"1,618","price_per_share":103.14854870210137,"price_display":"103.15","price_state":"stated","total_value":166894.3518,"total_display":"166,894.35","total_whole":"166,894","shares_owned_after":109320.0,"shares_owned_after_display":"109,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider","n_lines":2},{"id":7951788,"accession":"0001209191-19-057272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-057272","line_url":"/filing/0001209191-19-057272#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":115.98,"price_display":"115.98","price_state":"stated","total_value":579900.0,"total_display":"579,900.00","total_whole":"579,900","shares_owned_after":108408.0,"shares_owned_after_display":"108,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider"},{"id":8493800,"accession":"0001209191-19-055228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-055228","line_url":"/filing/0001209191-19-055228#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10188.0,"shares_display":"10,188","price_per_share":100.3433,"price_display":"100.34","price_state":"stated","total_value":1022297.5404,"total_display":"1,022,297.54","total_whole":"1,022,298","shares_owned_after":108408.0,"shares_owned_after_display":"108,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-05","scope":"insider"},{"id":7950557,"accession":"0001209191-19-043916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-043916","line_url":"/filing/0001209191-19-043916","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":92.92396666666667,"price_display":"92.92","price_state":"stated","total_value":5575438.0,"total_display":"5,575,438.00","total_whole":"5,575,438","shares_owned_after":118408.0,"shares_owned_after_display":"118,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-30","filed_date":"2019-07-31","scope":"insider","n_lines":2},{"id":8413621,"accession":"0001209191-19-030173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-030173","line_url":"/filing/0001209191-19-030173#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1657.0,"shares_display":"1,657","price_per_share":75.4419,"price_display":"75.44","price_state":"stated","total_value":125007.2283,"total_display":"125,007.23","total_whole":"125,007","shares_owned_after":118408.0,"shares_owned_after_display":"118,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":8189427,"accession":"0001209191-19-008638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-008638","line_url":"/filing/0001209191-19-008638#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531.0,"shares_display":"531","price_per_share":84.0331,"price_display":"84.03","price_state":"stated","total_value":44621.5761,"total_display":"44,621.58","total_whole":"44,622","shares_owned_after":120065.0,"shares_owned_after_display":"120,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-06","filed_date":"2019-02-08","scope":"insider"},{"id":8450668,"accession":"0001209191-19-007851","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-007851","line_url":"/filing/0001209191-19-007851","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1070.0,"shares_display":"1,070","price_per_share":88.1667,"price_display":"88.17","price_state":"stated","total_value":94338.369,"total_display":"94,338.37","total_whole":"94,338","shares_owned_after":118322.0,"shares_owned_after_display":"118,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-06","scope":"insider","n_lines":2},{"id":8450659,"accession":"0001209191-19-007851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-007851","line_url":"/filing/0001209191-19-007851#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1375.0,"shares_display":"1,375","price_per_share":88.1211,"price_display":"88.12","price_state":"stated","total_value":121166.5125,"total_display":"121,166.51","total_whole":"121,167","shares_owned_after":117066.0,"shares_owned_after_display":"117,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-04","filed_date":"2019-02-06","scope":"insider"},{"id":6155656,"accession":"0001209191-18-045264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-045264","line_url":"/filing/0001209191-18-045264#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23022.0,"shares_display":"23,022","price_per_share":110.0,"price_display":"110.00","price_state":"stated","total_value":2532420.0,"total_display":"2,532,420.00","total_whole":"2,532,420","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-03","scope":"insider"},{"id":6660814,"accession":"0001209191-18-039022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-039022","line_url":"/filing/0001209191-18-039022#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":2415000.0,"total_display":"2,415,000.00","total_whole":"2,415,000","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-20","filed_date":"2018-06-21","scope":"insider"},{"id":6455105,"accession":"0001209191-18-038093","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-038093","line_url":"/filing/0001209191-18-038093#line-6","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2785.0,"shares_display":"2,785","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":278500.0,"total_display":"278,500.00","total_whole":"278,500","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-14","filed_date":"2018-06-15","scope":"insider"},{"id":6455100,"accession":"0001209191-18-038093","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-038093","line_url":"/filing/0001209191-18-038093","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84178.0,"shares_display":"84,178","price_per_share":99.45874553089881,"price_display":"99.46","price_state":"stated","total_value":8372238.2813,"total_display":"8,372,238.28","total_whole":"8,372,238","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-13","filed_date":"2018-06-15","scope":"insider","n_lines":2},{"id":6859259,"accession":"0001209191-18-009522","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-009522","line_url":"/filing/0001209191-18-009522#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14593.0,"shares_display":"14,593","price_per_share":80.0009,"price_display":"80.00","price_state":"stated","total_value":1167453.1337,"total_display":"1,167,453.13","total_whole":"1,167,453","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-13","scope":"insider"},{"id":6859250,"accession":"0001209191-18-009522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-009522","line_url":"/filing/0001209191-18-009522#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71775.0,"shares_display":"71,775","price_per_share":77.9759,"price_display":"77.98","price_state":"stated","total_value":5596720.2225,"total_display":"5,596,720.22","total_whole":"5,596,720","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-09","filed_date":"2018-02-13","scope":"insider"},{"id":6042132,"accession":"0001209191-18-008212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-008212","line_url":"/filing/0001209191-18-008212","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2046.0,"shares_display":"2,046","price_per_share":83.08764301075269,"price_display":"83.09","price_state":"stated","total_value":169997.3176,"total_display":"169,997.32","total_whole":"169,997","shares_owned_after":80691.0,"shares_owned_after_display":"80,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider","n_lines":2},{"id":6630794,"accession":"0001209191-18-004244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-004244","line_url":"/filing/0001209191-18-004244#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":79.1157,"price_display":"79.12","price_state":"stated","total_value":128563.0125,"total_display":"128,563.01","total_whole":"128,563","shares_owned_after":79316.0,"shares_owned_after_display":"79,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":4360130,"accession":"0001209191-17-060286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-060286","line_url":"/filing/0001209191-17-060286#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":74.5781,"price_display":"74.58","price_state":"stated","total_value":2237343.0,"total_display":"2,237,343.00","total_whole":"2,237,343","shares_owned_after":77691.0,"shares_owned_after_display":"77,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-08","filed_date":"2017-11-13","scope":"insider"},{"id":4743161,"accession":"0001209191-17-048696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-048696","line_url":"/filing/0001209191-17-048696#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15354.0,"shares_display":"15,354","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":844470.0,"total_display":"844,470.00","total_whole":"844,470","shares_owned_after":107691.0,"shares_owned_after_display":"107,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-09","filed_date":"2017-08-14","scope":"insider"},{"id":4541046,"accession":"0001209191-17-034910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-034910","line_url":"/filing/0001209191-17-034910#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":53.39,"price_display":"53.39","price_state":"stated","total_value":533900.0,"total_display":"533,900.00","total_whole":"533,900","shares_owned_after":107691.0,"shares_owned_after_display":"107,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-23","filed_date":"2017-05-24","scope":"insider"},{"id":5068308,"accession":"0001209191-17-029801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-029801","line_url":"/filing/0001209191-17-029801#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":117691.0,"shares_owned_after_display":"117,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-03","scope":"insider"},{"id":4868745,"accession":"0001209191-17-026881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-026881","line_url":"/filing/0001209191-17-026881","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13065.0,"shares_display":"13,065","price_per_share":50.422803673938,"price_display":"50.42","price_state":"stated","total_value":658773.93,"total_display":"658,773.93","total_whole":"658,774","shares_owned_after":127895.0,"shares_owned_after_display":"127,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-12","filed_date":"2017-04-13","scope":"insider","n_lines":2},{"id":4828404,"accession":"0001209191-17-008917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008917","line_url":"/filing/0001209191-17-008917#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":727.0,"shares_display":"727","price_per_share":43.13,"price_display":"43.13","price_state":"stated","total_value":31355.51,"total_display":"31,355.51","total_whole":"31,356","shares_owned_after":115756.0,"shares_owned_after_display":"115,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider"},{"id":5155395,"accession":"0001209191-17-008133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008133","line_url":"/filing/0001209191-17-008133#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1375.0,"shares_display":"1,375","price_per_share":42.56,"price_display":"42.56","price_state":"stated","total_value":58520.0,"total_display":"58,520.00","total_whole":"58,520","shares_owned_after":114558.0,"shares_owned_after_display":"114,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-06","scope":"insider"},{"id":5031346,"accession":"0001209191-17-004302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-004302","line_url":"/filing/0001209191-17-004302#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":40.63,"price_display":"40.63","price_state":"stated","total_value":66023.75,"total_display":"66,023.75","total_whole":"66,024","shares_owned_after":113183.0,"shares_owned_after_display":"113,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-18","scope":"insider"},{"id":4410638,"accession":"0001209191-17-003587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-003587","line_url":"/filing/0001209191-17-003587#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":43.39,"price_display":"43.39","price_state":"stated","total_value":70508.75,"total_display":"70,508.75","total_whole":"70,509","shares_owned_after":111558.0,"shares_owned_after_display":"111,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-10","filed_date":"2017-01-12","scope":"insider"},{"id":2405249,"accession":"0001209191-16-095851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-095851","line_url":"/filing/0001209191-16-095851#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1375.0,"shares_display":"1,375","price_per_share":37.98,"price_display":"37.98","price_state":"stated","total_value":52222.5,"total_display":"52,222.50","total_whole":"52,223","shares_owned_after":109933.0,"shares_owned_after_display":"109,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-04","scope":"insider"},{"id":3118252,"accession":"0001209191-16-092888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-092888","line_url":"/filing/0001209191-16-092888#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":46.76,"price_display":"46.76","price_state":"stated","total_value":75985.0,"total_display":"75,985.00","total_whole":"75,985","shares_owned_after":108558.0,"shares_owned_after_display":"108,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-21","scope":"insider"},{"id":2200179,"accession":"0001209191-16-091254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091254","line_url":"/filing/0001209191-16-091254#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":44.21,"price_display":"44.21","price_state":"stated","total_value":71841.25,"total_display":"71,841.25","total_whole":"71,841","shares_owned_after":106933.0,"shares_owned_after_display":"106,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-13","scope":"insider"},{"id":8096934,"accession":"0001209191-15-082639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-082639","line_url":"/filing/0001209191-15-082639#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001423838","owner_name":"Grigoriadis Dimitri E.","owner_display_name":"Grigoriadis Dimitri E.","owner_url":"/insider/0001423838","role":"Officer (Chief Research Officer)","role_mark":"O","role_mark_label":"Officer (Chief Research Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Research Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":57.5,"price_display":"57.50","price_state":"stated","total_value":575000.0,"total_display":"575,000.00","total_whole":"575,000","shares_owned_after":105308.0,"shares_owned_after_display":"105,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-27","filed_date":"2015-12-01","scope":"insider"}],"collapsed":true,"next_cursor":"2015-11-27|8096934","ledger_fault":false,"count":{"value":88,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":88,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":88},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Research Officer)","n_filings":63,"first_seen":"2008-02-06","last_seen":"2021-10-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001423838","retrieved_at":"2026-08-24T03:18:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}